Allakos Share Price Today
(NASDAQ: ALLK)

Name: Allakos Share Price Today (NASDAQ: ALLK) - Allakos Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Allakos share price is $0.26 & ₹22.61 as on 6 Mar 2025, 2.30 'hrs' IST

$0.26

Market is closed - opens 8 PM, 06 Mar 2025

View live Allakos share price in Dollar and Rupees. Guide to invest in Allakos stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Allakos, along with analyst recommendations, forecasts, and comprehensive financials.

Allakos share price movements

Today's Low: $0.26
Today's High: $0.26
$0.26
1.92%
Downside
Day's Volatility :3.48%
Upside
1.59%
52 Weeks Low: $0.23
52 Weeks High: $1.56
$0.26
12.31%
Downside
52 Weeks Volatility :85.34%
Upside
83.28%

Allakos (ALLK) Returns

Period	Allakos Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-76.49%	2.1%	0.0%
6 Months	-62.08%	-4.1%	0.0%
1 Year	-79.95%	2.2%	0.0%
3 Years	-94.95%	11.8%	-11.6%

Allakos (ALLK) Key Statistics

in dollars & INR

Previous Close	$0.2586
Open	$0.2606
Today's High	$0.2642
Today's Low	$0.255
Market Capitalization	$24.1M
Today's Volume	$124.8K
52 Week High	$1.555
52 Week Low	$0.228
Revenue TTM	$0.0
EBITDA	$-154.7M
Earnings Per Share (EPS)	$-2.06
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-121.68%

How to invest in Allakos Stock (ALLK) from India?

It is very easy for Indian residents to invest directly in Allakos from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Allakos stock in both Indian Rupees (INR) and US Dollars (USD). Search for Allakos or ALLK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Allakos or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Allakos shares which would translate to 3.345 fractional shares of Allakos as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Allakos, in just a few clicks!

Returns in Allakos (ALLK) for Indian investors in Rupees

The Allakos stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Allakos investment value today

Current value as on today

₹25,118

Returns

₹74,882

(-74.88%)

Returns from Allakos Stock

₹79,845 (-79.84%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Allakos (ALLK)

-6%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Allakos Stock from India on INDmoney has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Allakos

Bvf Inc
18.53%
NEA Management Company, LLC
6.88%
Deep Track Capital, LP
6.38%
FMR Inc
6.06%
Point72 Asset Management, L.P.
4.02%
Vanguard Group Inc
3.84%

Analyst Recommendation on Allakos

Buy

53%Buy

40%Hold

6%Sell

Based on 15 Wall street analysts offering stock ratings for Allakos(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Allakos Stock (ALLK)

What analysts predicted

Upside of 34.62%

Target:

$0.35

Current:

$0.26

Insights on Allakos Stock (Ticker Symbol: ALLK)

Price Movement
In the last 3 months, ALLK stock has moved down by -76.5%
ALLK vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 143.8%
ALLK vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 142.7%

Allakos Technicals Summary

Sell

Neutral

Buy

Allakos is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Allakos (ALLK) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Allakos Inc	2.5%	-62.08%	-79.95%	-94.95%	-99.56%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Allakos Inc	NA	NA	NA	-1.49	-1.22	-0.49	NA	0.81
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Allakos Inc	Buy	$24.1M	-99.56%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Allakos

Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.

Organization	Allakos
Employees	131
CEO	Dr. Robert Alexander Ph.D.
Industry	Health Technology

Management People of Allakos

Name	Title
Dr. Robert Alexander Ph.D.	CEO & Director
Dr. Adam L. Tomasi Ph.D.	President
Mr. Baird Radford III	Chief Financial Officer
Mr. Alan Chang	Director of Medical Affairs & Data Analytics

Important FAQs about investing in ALLK Stock from India :

What is Allakos share price today?

Allakos share price today stands at $0.26, Open: $0.26 ; Previous Close: $0.26 ; High: $0.26 ; Low: $0.26 ; 52 Week High: $1.56 ; 52 Week Low: $0.23.

The stock opens at $0.26, after a previous close of $0.26. The stock reached a daily high of $0.26 and a low of $0.26, with a 52-week high of $1.56 and a 52-week low of $0.23.

Can Indians buy Allakos shares?

Yes, Indians can invest in the Allakos (ALLK) from India.

With INDmoney, you can buy Allakos at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Allakos at zero transaction cost.

How can I buy Allakos shares from India?

It is very easy to buy Allakos from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Allakos (ALLK) be purchased?

Yes, you can buy fractional shares of Allakos with INDmoney app.

What are the documents required to start investing in Allakos stocks?

To start investing in Allakos, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.